Search Results - "Hesley, Teresa M"

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years by Brown, Darron R., Kjaer, Susanne K., Sigurdsson, Kristján, Iversen, Ole-Erik, Hernandez-Avila, Mauricio, Wheeler, Cosette M., Perez, Gonzalo, Koutsky, Laura A., Tay, Eng Hseon, Garcia, Patricía, Ault, Kevin A., Garland, Suzanne M., Leodolter, Sepp, Olsson, Sven-Eric, Tang, Grace W. K., Ferris, Daron G., Paavonen, Jorma, Steben, Marc, Bosch, F. Xavier, Dillner, Joakim, Joura, Elmar A., Kurman, Robert J., Majewski, Slawomir, Muñoz, Nubia, Myers, Evan R., Villa, Luisa L., Taddeo, Frank J., Roberts, Christine, Tadesse, Amha, Bryan, Janine, Lupinacci, Lisa C., Giacoletti, Katherine E. D., Sings, Heather L., James, Margaret, Hesley, Teresa M., Barr, Eliav

“…BackgroundHuman papillomavirus (HPV)–6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18–related cervical intraepithelial neoplasia (CIN) 1–3 or…”
Get full text

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years by Wheeler, Cosette M., Kjaer, Susanne K., Sigurdsson, Kristján, Iversen, Ole-Erik, Hernandez-Avila, Mauricio, Perez, Gonzalo, Brown, Darron R., Koutsky, Laura A., Tay, Eng Hseon, García, Patricia, Ault, Kevin A., Garland, Suzanne M., Leodolter, Sepp, Olsson, Sven-Eric, Tang, Grace W. K., Ferris, Daron G., Paavonen, Jorma, Steben, Marc, Bosch, F. Xavier, Dillner, Joakim, Joura, Elmar A., Kurman, Robert J., Majewski, Slawomir, Muñoz, Nubia, Myers, Evan R., Villa, Luisa L., Taddeo, Frank J., Roberts, Christine, Tadesse, Amha, Bryan, Janine, Lupinacci, Lisa C., Giacoletti, Katherine E. D., James, Margaret, Vuocolo, Scott, Hesley, Teresa M., Barr, Eliav

“…BackgroundWe evaluated the impact of a quadrivalent human papillomavirus (HPV) vaccine on infection and cervical disease related to 10 nonvaccine HPV types…”
Get full text

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial by Dillner, Joakim, Kjaer, Susanne K, Wheeler, Cosette M, Sigurdsson, Kristján, Iversen, Ole-Erik, Hernandez-Avila, Mauricio, Perez, Gonzalo, Brown, Darron R, Koutsky, Laura A, Tay, Eng Hseon, García, Patricia, Ault, Kevin A, Garland, Suzanne M, Leodolter, Sepp, Olsson, Sven-Eric, Tang, Grace W K, Ferris, Daron G, Paavonen, Jorma, Lehtinen, Matti, Steben, Marc, Bosch, F Xavier, Joura, Elmar A, Majewski, Slawomir, Muñoz, Nubia, Myers, Evan R, Villa, Luisa L, Taddeo, Frank J, Roberts, Christine, Tadesse, Amha, Bryan, Janine T, Maansson, Roger, Lu, Shuang, Vuocolo, Scott, Hesley, Teresa M, Barr, Eliav, Haupt, Richard

“…Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal…”
Get full text

Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus– Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age by Diaz-Mitoma, Francisco, Halperin, Scott A, Tapiero, Bruce, Hoffenbach, Agnes, Zappacosta, Pamela S, Radley, David, Bradshaw, Susan, Martin, Jason C, Boslego, John W, Hesley, Teresa M, Bhuyan, Prakash K, Silber, Jeffrey L

“…Abstract The current recommended infant vaccination schedules require many injections at multiple sites, which increase stress for infants and parents and may…”
Get full text

Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus– Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age by Halperin, Scott A, Tapiero, Bruce, Diaz-Mitoma, Francisco, Law, Barbara J, Hoffenbach, Agnes, Zappacosta, Pamela S, Radley, David, McCarson, Barbara J, Martin, Jason C, Brackett, Laura E, Boslego, John W, Hesley, Teresa M, Bhuyan, Prakash K, Silber, Jeffrey L

“…Abstract Combination vaccines improve parental and provider satisfaction and schedule compliance by decreasing the number of injections. In a Phase 2,…”
Get full text

Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure by Watkins, Sandra L., Alexander, Steven R., Brewer, Eileen D., Hesley, Teresa M., West, David J., Chan, Ivan S.F., Mendelman, Paul, Bailey, Shelia M., Burns, Jane L., Hogg, Ronald J.

“…Background: Diminished antibody responses to the dosage of hepatitis B (HB) vaccine indicated for healthy adults has led to a greater dosage recommendation…”
Get full text

Concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: safety, tolerability and immunogenicity by HESLEY, TERESA M, REISINGER, KEITH S, SULLIVAN, BRADLEY J, JENSEN, ERIN H, STASIOROWSKI, SUSAN, MEECHAN, CATHY D, CHAN, CHRISTINA Y, WEST, DAVID J

“…BACKGROUND.The study was done to verify that concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine (Comvax),…”
Get full text

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women by Muñoz, Nubia, Kjaer, Susanne K., Sigurdsson, Kristján, Iversen, Ole-Erik, Hernandez-Avila, Mauricio, Wheeler, Cosette M., Perez, Gonzalo, Brown, Darron R., Koutsky, Laura A., Tay, Eng Hseon, Garcia, Patricía J., Ault, Kevin A., Garland, Suzanne M., Leodolter, Sepp, Olsson, Sven-Eric, Tang, Grace W. K., Ferris, Daron G., Paavonen, Jorma, Steben, Marc, Bosch, F. Xavier, Dillner, Joakim, Huh, Warner K., Joura, Elmar A., Kurman, Robert J., Majewski, Slawomir, Myers, Evan R., Villa, Luisa L., Taddeo, Frank J., Roberts, Christine, Tadesse, Amha, Bryan, Janine T., Lupinacci, Lisa C., Giacoletti, Katherine E. D., Sings, Heather L., James, Margaret K., Hesley, Teresa M., Barr, Eliav, Haupt, Richard M.

“…Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital…”
Get full text

Post-licensure comparative study of unusual high-pitched crying and prolonged crying following COMVAX™ and placebo versus PedvaxHIB™ and RECOMBIVAX HB™ in healthy infants by Kaplan, Karen M, Rusche, Steven A, Lakkis, Hassan D, Bottenfield, Gerald, Guerra, Fernando A, Guerrero, Juan, Keyserling, Harry, Felicione, Elise, Hesley, Teresa M, Boslego, John W

“…Background: In a previous clinical trial comparing COMVAX™ with its monovalent components, PedvaxHIB™ and RECOMBIVAX HB™, one of 92 comparisons of…”
Get full text

Safety and Immunogenicity of Two Formulations of a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae b Conjugate-Hepatitis B Vaccine in 15 to 18 Month-Old Children by Halperin, Scott A., Langley, Joanne M, Hesley, Teresa M., Zappacosta, Pamela S., Radley, David, Smith, Bruce, Hoffenbach, Agnès, Boslego, John, Silber, Jeffrey L.

“…Combination vaccines decrease the number of injections and improve parental satisfaction and vaccination schedule compliance. In a phase 1, randomized,…”
Get full text

Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy by West, D J, Watson, B, Lichtman, J, Hesley, T M, Hedberg, K

Get more information

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions by Kjaer, Susanne K, Sigurdsson, Kristján, Iversen, Ole-Erik, Hernandez-Avila, Mauricio, Wheeler, Cosette M, Perez, Gonzalo, Brown, Darron R, Koutsky, Laura A, Tay, Eng Hseon, García, Patricia, Ault, Kevin A, Garland, Suzanne M, Leodolter, Sepp, Olsson, Sven-Eric, Tang, Grace W K, Ferris, Daron G, Paavonen, Jorma, Lehtinen, Matti, Steben, Marc, Bosch, F Xavier, Dillner, Joakim, Joura, Elmar A, Majewski, Slawomir, Muñoz, Nubia, Myers, Evan R, Villa, Luisa L, Taddeo, Frank J, Roberts, Christine, Tadesse, Amha, Bryan, Janine, Maansson, Roger, Lu, Shuang, Vuocolo, Scott, Hesley, Teresa M, Saah, Alfred, Barr, Eliav, Haupt, Richard M

“…Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection from HPV 6/11/16/18-related cervical, vaginal, and vulvar disease through…”
Get full text

Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants by WEST, DAVID J, HESLEY, TERESA M, JONAS, LESLIE C, FEELEY, LOUISA K, BIRD, STEVEN R, BURKE, PAMELA, SADOFF, JERALD C

“…OBJECTIVE.To assess the safety, tolerability and immunogenicity of COMVAX™, a liquid, bivalent Haemophilus influenzae type b-hepatitis B vaccine, containing…”
Get full text

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine by Joura, Elmar A, Kjaer, Susanne K, Wheeler, Cosette M, Sigurdsson, Kristján, Iversen, Ole-Erik, Hernandez-Avila, Mauricio, Perez, Gonzalo, Brown, Darron R, Koutsky, Laura A, Tay, Eng Hseon, García, Patricia, Ault, Kevin A, Garland, Suzanne M, Leodolter, Sepp, Olsson, Sven-Eric, Tang, Grace W.K, Ferris, Daron G, Paavonen, Jorma, Lehtinen, Matti, Steben, Marc, Bosch, Xavier, Dillner, Joakim, Kurman, Robert J, Majewski, Slawomir, Muñoz, Nubia, Myers, Evan R, Villa, Luisa L, Taddeo, Frank J, Roberts, Christine, Tadesse, Amha, Bryan, Janine, Lupinacci, Lisa C, Giacoletti, Katherine E.D, Lu, Shuang, Vuocolo, Scott, Hesley, Teresa M, Haupt, Richard M, Barr, Eliav

“…Abstract The efficacy of the quadrivalent Human Papillomavirus (HPV) vaccine is thought to be mediated by humoral immunity. We evaluated the correlation…”
Get full text

Prophylactic Efficacy of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Women with Virological Evidence of HPV Infection by Villa, Luisa L., Perez, Gonzalo, Kjaer, Susanne Krueger, Paavonen, Jorma, Lehtinen, Matti, Munoz, Nubia, Sigurdsson, Kristjan, Hernandez-Avila, Mauricio, Iversen, Ole Eric, Thoresen, Steinar, Garcia, Patricia J., Majewski, Slawomir, Tay, Eng Hseon, Bosch, F. Xavier, Dillner, Joakim, Olsson, Sven-Eric, Ault, Kevin A., Brown, Darron R., Ferris, Daron G., Koutsky, Laura A., Kurman, Robert J., Myers, Evan R., Barr, Eliav, Boslego, John, Bryan, Janine, Esser, Mark T., Hesley, Teresa M., Nelson, Micki, Railkar, Radha, James, Margaret, Sattler, Carlos, Taddeo, Frank J., Thornton, Annemarie R., Vuocolo, Scott C.

“…Background. A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-like-particle (VLP) vaccine has been shown to be 95%–100% effective in…”
Get full text

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection by Olsson, Sven-Eric, Kjaer, Susanne K., Sigurdsson, Kristján, Iversen, Ole-Erik, Hernandez-Avila, Mauricio, Wheeler, Cosette M., Perez, Gonzalo, Brown, Darron R., Koutsky, Laura A., Hseon Tay, Eng, García, Patricia, Ault, Kevin A., Garland, Suzanne M., Leodolter, Sepp, Tang, Grace W.K., Ferris, Daron G., Paavonen, Jorma, Lehtinen, Jorma, Steben, Marc, Bosch, F. Xavier, Dillner, Joakim, Joura, Elmar, Majewski, Slawomir, Muñoz, Nubia, Myers, Evan R., Villa, Luisa L.

“…Objective In the quadrivalent (types 6/11/16/18) HPV vaccine (GARDASIL®/SILGARD®) clinical program, 73% of women aged 16-26 were naïve to all vaccine HPV…”
Get full text

Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children by Halperin, Scott A, Langley, Joanne M, Hesley, Teresa M, Zappacosta, Pamela S, Radley, David, Smith, Bruce, Hoffenbach, Agnes, Boslego, John, Silber, Jeffrey L

“…Combination vaccines decrease the number of injections and improve parental satisfaction and vaccination schedule compliance. In a phase 1, randomized,…”
Get full text

Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzaeb conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age by Halperin, Scott A, Tapiero, Bruce, Diaz-Mitoma, Francisco, Law, Barbara J, Hoffenbach, Agnes, Zappacosta, Pamela S, Radley, David, McCarson, Barbara J, Martin, Jason C, Brackett, Laura E, Boslego, John W, Hesley, Teresa M, Bhuyan, Prakash K, Silber, Jeffrey L

“…Combination vaccines improve parental and provider satisfaction and schedule compliance by decreasing the number of injections. In a Phase 2, randomized,…”
Get full text

A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults by Marsano, Luis S., West, David J., Chan, Ivan, Hesley, Teresa M., Cox, Jenny, Hackworth, Vernon, Greenberg, Richard N.

“…This study shows that two doses of a recombinant hepatitis B vaccine (10 μg or 20 μg of HBsAg per dose), administered 6 months apart to young, healthy adults,…”
Get full text

Quadrivalent Vaccine Against Human Papillomavirus to Prevent High-Grade Cervical Lesions

“…Virtually all cervical cancers result from infection by human papillomavirus (HPV), 70% of them by HPV types 16 and 18. A quadrivalent vaccine against HPV…”
Get full text